The palliative role of lasers in the treatment of melanoma.
Adjunct therapy
Cutaneous melanoma
Laser therapy
Metastasis
Palliative
Journal
Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462
Informations de publication
Date de publication:
25 May 2024
25 May 2024
Historique:
received:
06
02
2024
accepted:
26
04
2024
revised:
06
02
2024
medline:
25
5
2024
pubmed:
25
5
2024
entrez:
25
5
2024
Statut:
epublish
Résumé
Melanoma, accounting for a significant proportion of skin cancer-related deaths, has variable survival outcomes based on the stage at diagnosis and treatment efficacy. Traditional treatments, while effective, pose risks of scarring and systemic side effects. Laser therapy offers an emerging non-surgical alternative, with CO2 lasers particularly showing promise in palliative care.A comprehensive search was conducted using PubMed, focusing on laser therapy for melanoma treatment. The search included studies on both stand-alone and adjunct laser therapies, with inclusion criteria requiring peer-reviewed articles detailing treatment outcomes for primary, recurrent, or metastatic melanoma.The literature shows that laser therapy for melanoma falls into four major types when categorized by laser medium: solid-state, diode, pulse-dye, and gas (CO2). Data on solid-state lasers for melanoma are limited and their use remains controversial. However, one study with high-energy pulsed neodymium lasers reported a 5-year survival of 82.9% with minimal adverse effects for primary melanoma. CO2 laser therapy has been effective for palliative treatment, with one study showing 54.8% of patients with recurrent melanoma surviving 5.4 years post-ablation. For metastatic melanoma, numerous studies have shown that CO2 laser therapy can provide symptomatic relief and disease control. Combination therapies using lasers and immune-based therapies have demonstrated enhanced outcomes and immune activation, highlighting the potential of laser therapies in melanoma management.While traditional treatments remain the standard for primary melanoma, laser therapies, particularly CO2 laser ablation, show substantial promise in palliative care for metastatic melanoma. Careful patient selection and assessment are crucial for achieving positive outcomes.
Identifiants
pubmed: 38795247
doi: 10.1007/s00403-024-03107-9
pii: 10.1007/s00403-024-03107-9
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
244Informations de copyright
© 2024. The Author(s).
Références
Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA (2023) Cutaneous melanoma. Lancet Lond Engl 402(10400):485–502. https://doi.org/10.1016/S0140-6736(23)00821-8
doi: 10.1016/S0140-6736(23)00821-8
Davis LE, Shalin SC, Tackett AJ (2019) Current state of melanoma diagnosis and treatment. Cancer Biol Ther 20(11):1366–1379. https://doi.org/10.1080/15384047.2019.1640032
doi: 10.1080/15384047.2019.1640032
pubmed: 31366280
pmcid: 6804807
Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A (2021) Epidemiology of Melanoma. Med Sci Basel Switz 9(4):63. https://doi.org/10.3390/medsci9040063
doi: 10.3390/medsci9040063
Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34. https://doi.org/10.3322/caac.21551
doi: 10.3322/caac.21551
pubmed: 30620402
Sundararajan S, Thida AM, Yadlapati S, Koya S (2023) Metastatic Melanoma. In: StatPearls. StatPearls Publishing; Accessed November 1, 2023. http://www.ncbi.nlm.nih.gov/books/NBK470358/
Sharon E, Snast I, Lapidoth M et al (2021) Laser treatment for Non-melanoma skin Cancer: a systematic review and Meta-analysis. Am J Clin Dermatol 22(1):25–38. https://doi.org/10.1007/s40257-020-00562-8
doi: 10.1007/s40257-020-00562-8
pubmed: 32930983
Chan HHL, Xiang L, Leung JCK, Tsang KWT, Lai KN (2003) In vitro study examining the effect of sub-lethal QS 755 nm lasers on the expression of p16INK4a on melanoma cell lines. Lasers Surg Med 32(2):88–93. https://doi.org/10.1002/lsm.10118
doi: 10.1002/lsm.10118
pubmed: 12561040
Kopera D, Hohenleutner U, Stolz W, Landthaler M (1997) Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells. Dermatol Basel Switz 194(4):344–350. https://doi.org/10.1159/000246133
doi: 10.1159/000246133
Moskalik KG, Kozlov AP, Demin EV (2010) High-energy neodymium laser radiation for the treatment of face cutaneous melanoma. J BUON off J Balk Union Oncol 15(2):389–391
Gibson SC, Byrne DS, McKay AJ (2004) Ten-year experience of carbon dioxide laser ablation as treatment for cutaneous recurrence of malignant melanoma. Br J Surg 91(7):893–895. https://doi.org/10.1002/bjs.4558
doi: 10.1002/bjs.4558
pubmed: 15227697
Kandamany N, Mahaffey P (2009) Carbon dioxide laser ablation as first-line management of in-transit cutaneous malignant melanoma metastases. Lasers Med Sci 24(3):411–414. https://doi.org/10.1007/s10103-008-0580-0
doi: 10.1007/s10103-008-0580-0
pubmed: 18566850
Lingam MK, McKay AJ (1995) Carbon dioxide laser ablation as an alternative treatment for cutaneous metastases from malignant melanoma. Br J Surg 82(10):1346–1348. https://doi.org/10.1002/bjs.1800821016
doi: 10.1002/bjs.1800821016
pubmed: 7489160
van Jarwaarde JA, Wessels R, Nieweg OE, Wouters MWJM, van der Hage JA (2015) CO2 laser treatment for regional cutaneous malignant melanoma metastases. Dermatol Surg off Publ Am Soc Dermatol Surg Al 41(1):78–82. https://doi.org/10.1097/DSS.0000000000000251
doi: 10.1097/DSS.0000000000000251
Vrielink OM, Kruijff S, van Leeuwen BL, Roodenburg JL (2019) Application of CO2 laser evaporation in locally advanced melanoma. Melanoma Manag 6(1):MMT14. https://doi.org/10.2217/mmt-2018-0008
doi: 10.2217/mmt-2018-0008
pubmed: 31236206
pmcid: 6582456
Hill S, Thomas JM (1993) Treatment of cutaneous metastases from malignant melanoma using the carbon-dioxide laser. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 19(2):173–177
Hill S, Thomas JM (1996) Use of the carbon dioxide laser to manage cutaneous metastases from malignant melanoma. Br J Surg 83(4):509–512. https://doi.org/10.1002/bjs.1800830425
doi: 10.1002/bjs.1800830425
pubmed: 8665245
Chan LKW, Quaba AA (2012) Improving the quality of life in melanoma: the role of the CO(2) laser. J Cosmet Laser Ther off Publ Eur Soc Laser Dermatol 14(1):43–47. https://doi.org/10.3109/14764172.2011.649761
doi: 10.3109/14764172.2011.649761
Strobbe LJ, Nieweg OE, Kroon BB (1997) Carbon dioxide laser for cutaneous melanoma metastases: indications and limitations. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 23(5):435–438. https://doi.org/10.1016/s0748-7983(97)93726-4
doi: 10.1016/s0748-7983(97)93726-4
Chen DJ, Li XS, Zhao H et al (2017) Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: a clinical study. Oncol Lett 13(3):1425–1431. https://doi.org/10.3892/ol.2016.5530
doi: 10.3892/ol.2016.5530
pubmed: 28454272
Kottschade LA, Weenig RH, Otley CC, McWilliams RR, Markovic SN (2010) The use of pulsed dye laser in the treatment of melanoma metastatic to the skin: a Mayo Clinic case series. J Am Acad Dermatol 62(6):e22–25. https://doi.org/10.1016/j.jaad.2009.12.028
doi: 10.1016/j.jaad.2009.12.028
pubmed: 20466167
Zeitouni NC, Dawson K, Cheney RT (2005) Treatment of cutaneous metastatic melanoma with imiquimod 5% cream and the pulsed-dye laser. Br J Dermatol 152(2):376–377. https://doi.org/10.1111/j.1365-2133.2005.06307.x
doi: 10.1111/j.1365-2133.2005.06307.x
pubmed: 15727662
Naylor MF, Zhou F, Geister BV, Nordquist RE, Li X, Chen WR (2017) Treatment of advanced melanoma with laser immunotherapy and ipilimumab. J Biophotonics 10(5):618–622. https://doi.org/10.1002/jbio.201600271
doi: 10.1002/jbio.201600271
pubmed: 28417565
Li X, Naylor MF, Le H et al (2010) Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: a preliminary study. Cancer Biol Ther 10(11):1081–1087. https://doi.org/10.4161/cbt.10.11.13434
doi: 10.4161/cbt.10.11.13434
pubmed: 20890121
pmcid: 3047103
Testori A, Ribero S, Bataille V (2017) Diagnosis and treatment of in-transit melanoma metastases. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 43(3):544–560. https://doi.org/10.1016/j.ejso.2016.10.005
doi: 10.1016/j.ejso.2016.10.005
Hoekstra HJ (2008) The European approach to in-transit melanoma lesions. Int J Hyperth off J Eur Soc Hyperthermic Oncol North Am Hyperth Group 24(3):227–237. https://doi.org/10.1080/02656730701816402
doi: 10.1080/02656730701816402
Bagge ASL, Ben-Shabat I, Belgrano V, Olofsson Bagge R (2016) Health-Related Quality of Life for patients who have In-Transit Melanoma Metastases Treated with isolated limb perfusion. Ann Surg Oncol 23(6):2062–2069. https://doi.org/10.1245/s10434-016-5103-9
doi: 10.1245/s10434-016-5103-9
pubmed: 26868956
Pathak S, Zito PM (2023) Clinical Guidelines for the Staging, Diagnosis, and Management of Cutaneous Malignant Melanoma. In: StatPearls. StatPearls Publishing; Accessed January 4, 2024. http://www.ncbi.nlm.nih.gov/books/NBK572149/
National Comprehensive Cancer Network (2023) NCCN Clinical Practice Guidelines in Oncology: cutaneous melanoma. Version 1.2023. National Comprehensive Cancer Network
Delker S, Livingstone E, Schimming T, Schadendorf D, Griewank KG (2017) Melanoma diagnosed in lesions previously treated by laser therapy. J Dermatol 44(1):23–28. https://doi.org/10.1111/1346-8138.13484
doi: 10.1111/1346-8138.13484
pubmed: 27345456
Zipser MC, Mangana J, Oberholzer PA, French LE, Dummer R (2010) Melanoma after laser therapy of pigmented lesions–circumstances and outcome. Eur J Dermatol EJD 20(3):334–338. https://doi.org/10.1684/ejd.2010.0933
doi: 10.1684/ejd.2010.0933
pubmed: 20423817
Niiyama N, Niiyama S, Takasu H, Katsuoka K (2007) Progression of lentigo maligna into lentigo maligna melanoma following laser treatment. Eur J Dermatol EJD 17(3):252–253. https://doi.org/10.1684/ejd.2007.0167
doi: 10.1684/ejd.2007.0167
pubmed: 17478397
Woodrow SL, Burrows NP (2003) Malignant melanoma occurring at the periphery of a giant congenital naevus previously treated with laser therapy. Br J Dermatol 149(4):886–888. https://doi.org/10.1046/j.1365-2133.2003.05591.x
doi: 10.1046/j.1365-2133.2003.05591.x
pubmed: 14616388
Böer A, Wolter M, Kaufmann R (2003) [Pseudomelanoma following laser treatment or laser-treated melanoma?]. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG 1(1):47–50. https://doi.org/10.1046/j.1610-0387.2003.02002.x
doi: 10.1046/j.1610-0387.2003.02002.x
Gottschaller C, Hohenleutner U, Landthaler M (2006) Metastasis of a malignant melanoma 2 years after carbon dioxide laser treatment of a pigmented lesion: case report and review of the literature. Acta Derm Venereol 86(1):44–47. https://doi.org/10.1080/00015550510044154
doi: 10.1080/00015550510044154
pubmed: 16585989